Compounds, compositions and methods are provided for modulating the expression of AP-2 alpha. The compositions comprise oligonucleotides, targeted to nucleic acid encoding AP-2 alpha. Methods of using these compounds for modulation of AP-2 alpha expression and for diagnosis and treatment of disease associated with expression of AP-2 alpha are provided.
展开▼